EP0194838A2 — Controlled-release pharmaceutical formulation
Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 1986-09-17 · 40y expired
What this patent protects
A pharmaceutical controlled release formulation is disclosed which does not substantially disintegrate but gradually releases a physiologically active substance in the gastrointestinal tract and which comprises a granulation product - (granules) obtained by adding release control…
USPTO Abstract
A pharmaceutical controlled release formulation is disclosed which does not substantially disintegrate but gradually releases a physiologically active substance in the gastrointestinal tract and which comprises a granulation product - (granules) obtained by adding release controlling agent (e.g. an aqueous suspension of a water insoluble macromolecular substance, an aqueous emulsion thereof, a water containing organic-solvent solution thereof, or water) to a mixture of i) physiologically active substance and ii) carrier substance (e.g. crystalline cellulose) in an amount of at least 5 0% by weight based on the weight of the product, and granulating the resultant mixture. The active substance containing granules have a high mechanical strength, disperse widely in the gastrointestinal tract when administered, are water permeable but do not substantially disintegrate in the gastrointestinal tract
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.